Fundz

UroMems raised $47 million in Series C funding led by Crédit Mutuel Innovation and joined by European Innovation Council

PRIVATEJun 25, 2024

Amount Raised

$47 Million

Round Type

Series C

GrenobleBiotechnologyHealth CareMedical Device

Investors

Financière ArbevelB To V PartnersHil InventSupernova InvestBpifranceWellington PartnersEuropean Innovation CouncilCrédit Mutuel Innovation

Description

UroMems raised a record $47 million in its Series C financing to fund pivotal clinical trials of the UroActive™ System, the first smart automated implant to treat stress urinary incontinence. The capital will support large-scale U.S. and European pivotal clinical trials of the UroActive™ implant, paving the way for regulatory submission in multiple countries.

Quick answer

UroMems raised $47 Million in a Series C round, dated June 25, 2024. Investors: Financière Arbevel, B To V Partners, Hil Invent, Supernova Invest, Bpifrance, Wellington Partners, European Innovation Council and Crédit Mutuel Innovation. UroMems is based in Grenoble, Auvergne Rhône Alpes, France.

How much did UroMems raise?
UroMems raised $47 Million in a Series C round on June 25, 2024.
Who invested in UroMems?
Financière Arbevel, B To V Partners, Hil Invent, Supernova Invest, Bpifrance, Wellington Partners, European Innovation Council and Crédit Mutuel Innovation are named as investors in this round.
What does UroMems do?
UroActive is an active implantable electronic artificial urinary sphincter that is being developed to compensate for sphincter insufficiency in patients, both men and women, with SUI.
Where is UroMems based and how big is it?
UroMems is based in Grenoble, Auvergne Rhône Alpes, France. Fundz records about 81 employees.
Who are the decision-makers at UroMems?
Fundz holds 3 contacts at UroMems, including the Human Resources Business Partner. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical Device and Biotechnology around the same time

Companies in the same sectors as UroMems that raised within 45 days of this round, from Fundz verified event records.

  • Xtant Medical Holdings raised $5M on August 9, 2024.
  • SigTuple raised $4M (Series C) on August 6, 2024.
  • NeuroOne Medical Technologies Corporation raised $276K on August 2, 2024.
  • Protembis GmbH raised $22M (Debt Financing) on July 30, 2024.
  • Otolith Labs raised $4.9M (Series A) on July 29, 2024.
  • 4D Medicine raised $4.4M (Series A) on July 26, 2024.

Who to call at UroMems, and when

A new round usually means UroMems is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day UroMems raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at UroMems, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at UroMems. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

UroMems

Location

Grenoble, Auvergne Rhône Alpes, France

About

UroActive is an active implantable electronic artificial urinary sphincter that is being developed to compensate for sphincter insufficiency in patients, both men and women, with SUI. It is based on a unique bionic platform using embedded smart, digital and robotic systems which, based on data collected from a patient, create a treatment algorithm that is specific for each patient's needs. The UroMems technology platform is protected by more than 150 patents and is designed to overcome the limitations of current solutions by optimizing safety and performance, patient experience and surgeon convenience. UroActive has not received marketing authorization from the FDA and is not available for sale in the United States or in the EU.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment UroMems raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsOksana S., Human Resources Business Partner hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for UroMems's next move

See what Strategic adds

UroMems raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.